Which has preferable valuation & earnings, EXE or SIA?

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Extendicare C$1.75B 1.92 C$65.46M C$1.36 26.11 Sienna Senior Living C$1.05B 2.26 C$33.51M C$0.48 46.44

Does the media favor EXE or SIA?

In the previous week, Extendicare and Extendicare both had 2 articles in the media. Extendicare's average media sentiment score of 1.27 beat Sienna Senior Living's score of 0.67 indicating that Extendicare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Extendicare 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sienna Senior Living 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, EXE or DNTL?

Extendicare has higher revenue and earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Extendicare C$1.75B 1.92 C$65.46M C$1.36 26.11 dentalcorp C$1.66B 1.32 -C$80.68M -C$0.14 N/A

Does the media refer more to EXE or DNTL?

In the previous week, Extendicare had 1 more articles in the media than dentalcorp. MarketBeat recorded 2 mentions for Extendicare and 1 mentions for dentalcorp. Extendicare's average media sentiment score of 1.27 beat dentalcorp's score of 0.00 indicating that Extendicare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Extendicare 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive dentalcorp 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer WELL or EXE?

In the previous week, Extendicare had 1 more articles in the media than WELL Health Technologies. MarketBeat recorded 2 mentions for Extendicare and 1 mentions for WELL Health Technologies. Extendicare's average media sentiment score of 1.27 beat WELL Health Technologies' score of 0.99 indicating that Extendicare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment WELL Health Technologies 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Extendicare 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer DR or EXE?

Extendicare has a consensus price target of C$32.56, indicating a potential downside of 8.24%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Medical Facilities. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medical Facilities 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Extendicare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25

Which has better valuation & earnings, DR or EXE?

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medical Facilities C$260.72M 1.18 C$17.17M C$1.94 9.00 Extendicare C$1.75B 1.92 C$65.46M C$1.36 26.11

Do analysts rate NLH or EXE?

Extendicare has a consensus price target of C$32.56, suggesting a potential downside of 8.24%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Nova Leap Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nova Leap Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Extendicare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25

Which has better earnings & valuation, NLH or EXE?

Extendicare has higher revenue and earnings than Nova Leap Health. Extendicare is trading at a lower price-to-earnings ratio than Nova Leap Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nova Leap Health C$32.23M 1.18 -C$300.30K C$0.00 145.00 Extendicare C$1.75B 1.92 C$65.46M C$1.36 26.11

Extendicare (EXE) Competitors

C$35.48 0.00 (0.00%)

As of 07/31/2026 04:00 PM Eastern

Compare

EXE vs. SIA, DNTL, WELL, DR, and NLH

Should you buy Extendicare stock or one of its competitors? MarketBeat compares Extendicare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Extendicare include Sienna Senior Living (SIA), dentalcorp (DNTL), WELL Health Technologies (WELL), Medical Facilities (DR), and Nova Leap Health (NLH).

How does Extendicare compare to Sienna Senior Living?

Extendicare (TSE:EXE) and Sienna Senior Living (TSE:SIA) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, media sentiment, risk and valuation.

Extendicare has a net margin of 6.99% compared to Sienna Senior Living's net margin of 4.34%. Extendicare's return on equity of 45.35% beat Sienna Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	6.99%	45.35%	7.16%
Sienna Senior Living	4.34%	6.44%	3.58%

In the previous week, Extendicare and Extendicare both had 2 articles in the media. Extendicare's average media sentiment score of 1.27 beat Sienna Senior Living's score of 0.67 indicating that Extendicare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Extendicare	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sienna Senior Living	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.4%. Sienna Senior Living pays an annual dividend of C$0.94 per share and has a dividend yield of 4.2%. Extendicare pays out 37.2% of its earnings in the form of a dividend. Sienna Senior Living pays out 195.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Extendicare presently has a consensus price target of C$32.56, indicating a potential downside of 8.24%. Sienna Senior Living has a consensus price target of C$26.09, indicating a potential upside of 17.05%. Given Sienna Senior Living's higher possible upside, analysts clearly believe Sienna Senior Living is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25
Sienna Senior Living	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.75B	1.92	C$65.46M	C$1.36	26.11
Sienna Senior Living	C$1.05B	2.26	C$33.51M	C$0.48	46.44

29.8% of Extendicare shares are held by institutional investors. Comparatively, 29.6% of Sienna Senior Living shares are held by institutional investors. 13.9% of Extendicare shares are held by company insiders. Comparatively, 0.1% of Sienna Senior Living shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Extendicare has a beta of 1.580825, suggesting that its share price is 58% more volatile than the broader market. Comparatively, Sienna Senior Living has a beta of 1.059779, suggesting that its share price is 6% more volatile than the broader market.

Summary

Extendicare beats Sienna Senior Living on 13 of the 18 factors compared between the two stocks.

How does Extendicare compare to dentalcorp?

Extendicare (TSE:EXE) and dentalcorp (TSE:DNTL) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.4%. dentalcorp pays an annual dividend of C$0.08 per share and has a dividend yield of 0.7%. Extendicare pays out 37.2% of its earnings in the form of a dividend. dentalcorp pays out -53.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Extendicare has a beta of 1.580825, indicating that its share price is 58% more volatile than the broader market. Comparatively, dentalcorp has a beta of 1.469634, indicating that its share price is 47% more volatile than the broader market.

Extendicare has a net margin of 6.99% compared to dentalcorp's net margin of -1.12%. Extendicare's return on equity of 45.35% beat dentalcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	6.99%	45.35%	7.16%
dentalcorp	-1.12%	-0.80%	0.77%

In the previous week, Extendicare had 1 more articles in the media than dentalcorp. MarketBeat recorded 2 mentions for Extendicare and 1 mentions for dentalcorp. Extendicare's average media sentiment score of 1.27 beat dentalcorp's score of 0.00 indicating that Extendicare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Extendicare	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
dentalcorp	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Extendicare has higher revenue and earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.75B	1.92	C$65.46M	C$1.36	26.11
dentalcorp	C$1.66B	1.32	-C$80.68M	-C$0.14	N/A

Extendicare currently has a consensus price target of C$32.56, suggesting a potential downside of 8.24%. dentalcorp has a consensus price target of C$11.00, suggesting a potential upside of 0.00%. Given dentalcorp's higher probable upside, analysts plainly believe dentalcorp is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25
dentalcorp	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

29.8% of Extendicare shares are held by institutional investors. Comparatively, 17.9% of dentalcorp shares are held by institutional investors. 13.9% of Extendicare shares are held by insiders. Comparatively, 0.2% of dentalcorp shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Extendicare beats dentalcorp on 17 of the 19 factors compared between the two stocks.

How does Extendicare compare to WELL Health Technologies?

WELL Health Technologies (TSE:WELL) and Extendicare (TSE:EXE) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

5.4% of WELL Health Technologies shares are held by institutional investors. Comparatively, 29.8% of Extendicare shares are held by institutional investors. 6.8% of WELL Health Technologies shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

WELL Health Technologies presently has a consensus target price of C$7.13, suggesting a potential upside of 76.36%. Extendicare has a consensus target price of C$32.56, suggesting a potential downside of 8.24%. Given WELL Health Technologies' higher possible upside, research analysts plainly believe WELL Health Technologies is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WELL Health Technologies	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

WELL Health Technologies has higher earnings, but lower revenue than Extendicare. Extendicare is trading at a lower price-to-earnings ratio than WELL Health Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WELL Health Technologies	C$1.47B	0.70	C$73.76M	C$0.11	36.73
Extendicare	C$1.75B	1.92	C$65.46M	C$1.36	26.11

WELL Health Technologies has a beta of 0.900556, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, Extendicare has a beta of 1.580825, suggesting that its stock price is 58% more volatile than the broader market.

Extendicare has a net margin of 6.99% compared to WELL Health Technologies' net margin of 1.82%. Extendicare's return on equity of 45.35% beat WELL Health Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
WELL Health Technologies	1.82%	3.15%	2.07%
Extendicare	6.99%	45.35%	7.16%

In the previous week, Extendicare had 1 more articles in the media than WELL Health Technologies. MarketBeat recorded 2 mentions for Extendicare and 1 mentions for WELL Health Technologies. Extendicare's average media sentiment score of 1.27 beat WELL Health Technologies' score of 0.99 indicating that Extendicare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
WELL Health Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Extendicare	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Extendicare beats WELL Health Technologies on 14 of the 17 factors compared between the two stocks.

How does Extendicare compare to Medical Facilities?

Medical Facilities (TSE:DR) and Extendicare (TSE:EXE) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings and profitability.

Extendicare has a consensus price target of C$32.56, indicating a potential downside of 8.24%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Medical Facilities.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medical Facilities	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

16.5% of Medical Facilities shares are held by institutional investors. Comparatively, 29.8% of Extendicare shares are held by institutional investors. 0.4% of Medical Facilities shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Medical Facilities has a beta of 0.496135, meaning that its share price is 50% less volatile than the broader market. Comparatively, Extendicare has a beta of 1.580825, meaning that its share price is 58% more volatile than the broader market.

Medical Facilities has a net margin of 14.01% compared to Extendicare's net margin of 6.99%. Medical Facilities' return on equity of 51.33% beat Extendicare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medical Facilities	14.01%	51.33%	13.60%
Extendicare	6.99%	45.35%	7.16%

Medical Facilities pays an annual dividend of C$0.26 per share and has a dividend yield of 1.5%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.4%. Medical Facilities pays out 13.4% of its earnings in the form of a dividend. Extendicare pays out 37.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Medical Facilities is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Extendicare had 2 more articles in the media than Medical Facilities. MarketBeat recorded 2 mentions for Extendicare and 0 mentions for Medical Facilities. Extendicare's average media sentiment score of 1.27 beat Medical Facilities' score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Overall Sentiment
Medical Facilities	Neutral
Extendicare	Positive

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medical Facilities	C$260.72M	1.18	C$17.17M	C$1.94	9.00
Extendicare	C$1.75B	1.92	C$65.46M	C$1.36	26.11

Summary

Extendicare beats Medical Facilities on 13 of the 19 factors compared between the two stocks.

How does Extendicare compare to Nova Leap Health?

Nova Leap Health (CVE:NLH) and Extendicare (TSE:EXE) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

In the previous week, Extendicare had 2 more articles in the media than Nova Leap Health. MarketBeat recorded 2 mentions for Extendicare and 0 mentions for Nova Leap Health. Extendicare's average media sentiment score of 1.27 beat Nova Leap Health's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Overall Sentiment
Nova Leap Health	Neutral
Extendicare	Positive

Extendicare has a net margin of 6.99% compared to Nova Leap Health's net margin of 0.64%. Extendicare's return on equity of 45.35% beat Nova Leap Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nova Leap Health	0.64%	1.10%	2.77%
Extendicare	6.99%	45.35%	7.16%

Extendicare has higher revenue and earnings than Nova Leap Health. Extendicare is trading at a lower price-to-earnings ratio than Nova Leap Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nova Leap Health	C$32.23M	1.18	-C$300.30K	C$0.00	145.00
Extendicare	C$1.75B	1.92	C$65.46M	C$1.36	26.11

Extendicare has a consensus price target of C$32.56, suggesting a potential downside of 8.24%. Given Extendicare's stronger consensus rating and higher possible upside, analysts plainly believe Extendicare is more favorable than Nova Leap Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nova Leap Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

Nova Leap Health has a beta of 1.695796, indicating that its share price is 70% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.580825, indicating that its share price is 58% more volatile than the broader market.

0.0% of Nova Leap Health shares are owned by institutional investors. Comparatively, 29.8% of Extendicare shares are owned by institutional investors. 40.8% of Nova Leap Health shares are owned by company insiders. Comparatively, 13.9% of Extendicare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Extendicare beats Nova Leap Health on 14 of the 17 factors compared between the two stocks.

Get Extendicare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EXE vs. The Competition

Export

Metric	Extendicare	Healthcare Providers & Services Industry	Healthcare Sector	TSE Exchange
Market Cap	C$3.36B	C$9.93B	C$6.86B	C$12.25B
Dividend Yield	1.45%	2.54%	2.60%	6.20%
P/E Ratio	26.11	25.38	280.72	33.59
Price / Sales	1.92	4.92	588.04	9.16
Price / Cash	3.20	26.44	28.64	82.29
Price / Book	8.61	5.22	11.02	4.33
Net Income	C$65.46M	C$312.25M	C$3.48B	C$299.09M
7 Day Performance	-7.56%	-0.20%	0.56%	-0.53%
1 Month Performance	-5.03%	-0.89%	-4.14%	-1.72%
1 Year Performance	189.16%	27.08%	63.23%	32.66%

Extendicare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EXE Extendicare	2.3439 of 5 stars	C$35.48 flat	C$32.56 -8.2%	+189.2%	C$3.36B	C$1.75B	26.11	23,000	Dividend Announcement Ex-Dividend
SIA Sienna Senior Living	3.1697 of 5 stars	C$23.31 +1.1%	C$26.09 +11.9%	+24.4%	C$2.47B	C$1.05B	48.56	12,000	News Coverage Dividend Announcement Ex-Dividend
DNTL dentalcorp	0.021 of 5 stars	C$11.00 +0.1%	C$11.00	+38.9%	C$2.19B	C$1.66B	N/A	9,950
WELL WELL Health Technologies	3.836 of 5 stars	C$4.01 +0.5%	C$7.13 +77.7%	-12.7%	C$1.02B	C$1.47B	36.45	510
DR Medical Facilities	N/A	C$18.10 +0.3%	N/A	+20.7%	C$317.66M	C$260.72M	9.33	1,833

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:EXE) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Extendicare (EXE) Competitors

EXE vs. SIA, DNTL, WELL, DR, and NLH

How does Extendicare compare to Sienna Senior Living?

Summary

How does Extendicare compare to dentalcorp?

Summary

How does Extendicare compare to WELL Health Technologies?

Summary

How does Extendicare compare to Medical Facilities?

Summary

How does Extendicare compare to Nova Leap Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Extendicare (EXE) Competitors

EXE vs. SIA, DNTL, WELL, DR, and NLH

How does Extendicare compare to Sienna Senior Living?

Is EXE or SIA more profitable?

Does the media favor EXE or SIA?

Is EXE or SIA a better dividend stock?

Do analysts rate EXE or SIA?

Which has preferable valuation & earnings, EXE or SIA?

Do insiders and institutionals believe in EXE or SIA?

Which has more volatility and risk, EXE or SIA?

Summary

How does Extendicare compare to dentalcorp?

Is EXE or DNTL a better dividend stock?

Which has more volatility and risk, EXE or DNTL?

Is EXE or DNTL more profitable?

Does the media refer more to EXE or DNTL?

Which has stronger valuation & earnings, EXE or DNTL?

Do analysts rate EXE or DNTL?

Do institutionals & insiders have more ownership in EXE or DNTL?

Summary

How does Extendicare compare to WELL Health Technologies?

Do insiders & institutionals have more ownership in WELL or EXE?

Do analysts prefer WELL or EXE?

Which has preferable earnings & valuation, WELL or EXE?

Which has more risk and volatility, WELL or EXE?

Is WELL or EXE more profitable?

Does the media prefer WELL or EXE?

Summary

How does Extendicare compare to Medical Facilities?

Do analysts prefer DR or EXE?

Do institutionals & insiders have more ownership in DR or EXE?

Which has more risk & volatility, DR or EXE?

Is DR or EXE more profitable?

Is DR or EXE a better dividend stock?

Does the media refer more to DR or EXE?

Which has better valuation & earnings, DR or EXE?

Summary

How does Extendicare compare to Nova Leap Health?

Does the media refer more to NLH or EXE?

Is NLH or EXE more profitable?

Which has better earnings & valuation, NLH or EXE?

Do analysts rate NLH or EXE?

Which has more volatility & risk, NLH or EXE?

Do institutionals and insiders hold more shares of NLH or EXE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools